Inovio Pharmaceuticals Investor Relations Material
Latest events
Q4 2024
Inovio Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Inovio Pharmaceuticals Inc
Access all reports
Inovio Pharmaceuticals Inc. (INO) is a publicly traded biotechnology company headquartered in Plymouth Meeting, Pennsylvania. Inovio is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of DNA medicines to treat and prevent children and adults from infectious diseases as well as cancers. The Company uses its proprietary electroporation delivery technology to create enhanced cellular uptake of therapeutic DNA payload into target cells across multiple routes of administration.
Key slides for Inovio Pharmaceuticals Inc
The Citizens JMP Life Sciences Conference
Inovio Pharmaceuticals Inc
The Citizens JMP Life Sciences Conference
Inovio Pharmaceuticals Inc
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
INO
Country
🇺🇸 United States